Rotate injection sites daily, maintaining at least 1-2 inches between sites to prevent tissue irritation
Abstract Purpose of review To evaluate the evidence supporting combined sodium-glucose cotransporter 2 inhibitors (SGLT2is) and glucagon-like peptide-1 receptor agonists (GLP-1RAs) in type 2 diabetes, focusing on cardiometabolic outcomes and practical treatment approaches
Therefore, GLP-1 analogues have been found to have several non-glycaemic effects including improved blood pressure through arterial vasodilation and increased renal natriuresis and reduced appetite via delayed gastric emptying and centrally mediated satiety within the hypothalamus
Vitamin C helps in this recycling process
Nicotinamide mononucleotide (NMN) is a derivative of the B-vitamin niacin that dramatically improves health and longevity by serving as a precursor to NAD+, a compound that plays a crucial role in energy production, metabolism and gene expression in the body
Precision matters in GLP-1 administration because improper timing, food interactions, or inadequate dose escalation can reduce efficacy or trigger unnecessary side effects
